Patient,Sample,Sample_Type,Drug_Name,Drug_CID,Response,TCGA_Code,Prediction
TCGA-AC-A62V,TCGA-AC-A62V-01A-11R-A31O-07,Primary Tumor,Paclitaxel,36314,Partial Response,BRCA,-2.8704033
TCGA-OL-A5S0,TCGA-OL-A5S0-01A-11R-A28M-07,Primary Tumor,TAXOL,36314,Complete Response,BRCA,-3.730425
TCGA-CE-A481,TCGA-CE-A481-01A-21R-A23W-07,Primary Tumor,Doxorubicin,31703,Complete Response,THCA,-1.1386914
TCGA-CE-A482,TCGA-CE-A482-01A-11R-A23W-07,Primary Tumor,Doxorubicin,31703,Complete Response,THCA,-1.0082371
TCGA-A5-A1OH,TCGA-A5-A1OH-01A-21R-A22K-07,Primary Tumor,Carboplatin,426756,Complete Response,UCEC,3.0122888
TCGA-A5-A3LP,TCGA-A5-A3LP-01A-11R-A22K-07,Primary Tumor,Carboplatin,426756,Complete Response,UCEC,3.946244
TCGA-BG-A2L7,TCGA-BG-A2L7-01A-11R-A18M-07,Primary Tumor,Carboplatin,426756,Complete Response,UCEC,2.834434
TCGA-DI-A2QY,TCGA-DI-A2QY-01A-12R-A19W-07,Primary Tumor,Paclitaxel,36314,Complete Response,UCEC,-3.8711767
TCGA-DI-A2QY,TCGA-DI-A2QY-11A-11R-A19W-07,Solid Tissue Normal,Paclitaxel,36314,Complete Response,UCEC,-3.5308156
TCGA-QF-A5YT,TCGA-QF-A5YT-01A-11R-A31O-07,Primary Tumor,Cisplatin,5702198,Complete Response,UCEC,3.0155773
TCGA-AA-3662,TCGA-AA-3662-11A-01R-1723-07,Solid Tissue Normal,Capecitabine,60953,Partial Response,COAD,1.1137844
TCGA-AA-3662,TCGA-AA-3662-01A-01R-1723-07,Primary Tumor,Capecitabine,60953,Partial Response,COAD,1.092191
TCGA-AA-3713,TCGA-AA-3713-11A-01R-1723-07,Solid Tissue Normal,5-Fluorouracil,3385,Partial Response,COAD,3.698537
TCGA-AA-3713,TCGA-AA-3713-01A-21R-1723-07,Primary Tumor,5-Fluorouracil,3385,Partial Response,COAD,1.9697602
TCGA-AA-3930,TCGA-AA-3930-01A-01R-1022-07,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,COAD,0.394557
TCGA-AA-3994,TCGA-AA-3994-01A-01R-1113-07,Primary Tumor,Capecitabine,60953,Complete Response,COAD,0.8360976
TCGA-AA-A00J,TCGA-AA-A00J-01A-02R-A002-07,Primary Tumor,5-Fluorouracil,3385,Partial Response,COAD,3.5983224
TCGA-AD-6889,TCGA-AD-6889-01A-11R-1928-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,0.5197829
TCGA-AD-6901,TCGA-AD-6901-01A-11R-1928-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,0.6077442
TCGA-AZ-4616,TCGA-AZ-4616-01A-21R-1839-07,Primary Tumor,XELODA,60953,Stable Disease,COAD,0.6369802
TCGA-AZ-6606,TCGA-AZ-6606-01A-11R-1839-07,Primary Tumor,5 FU,3385,Clinical Progressive Disease,COAD,2.1964533
TCGA-F4-6805,TCGA-F4-6805-01A-11R-1839-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,0.55781806
TCGA-F4-6807,TCGA-F4-6807-01A-11R-1839-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,0.5550449
TCGA-QG-A5YV,TCGA-QG-A5YV-01A-11R-A28H-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,0.4440961
TCGA-QG-A5YX,TCGA-QG-A5YX-01A-11R-A28H-07,Primary Tumor,Xeloda,60953,Complete Response,COAD,0.95035446
TCGA-2W-A8YY,TCGA-2W-A8YY-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.2855806
TCGA-C5-A1BQ,TCGA-C5-A1BQ-01C-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.994165
TCGA-DS-A5RQ,TCGA-DS-A5RQ-01A-11R-A28H-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9883859
TCGA-DS-A7WF,TCGA-DS-A7WF-01A-11R-A352-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,2.3651826
TCGA-DS-A7WH,TCGA-DS-A7WH-01A-22R-A352-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,3.0355866
TCGA-DS-A7WI,TCGA-DS-A7WI-01A-12R-A352-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.1510692
TCGA-EA-A3QD,TCGA-EA-A3QD-01A-32R-A22U-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.177561
TCGA-EK-A2H0,TCGA-EK-A2H0-01A-11R-A180-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.4497182
TCGA-EK-A2RL,TCGA-EK-A2RL-01A-11R-A18M-07,Primary Tumor,Taxol,36314,Clinical Progressive Disease,CESC,-4.439894
TCGA-EX-A3L1,TCGA-EX-A3L1-01A-11R-A32Y-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5735583
TCGA-FU-A23L,TCGA-FU-A23L-01A-11R-A16R-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.650377
TCGA-FU-A3HY,TCGA-FU-A3HY-01A-11R-A21T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.314312
TCGA-FU-A3HZ,TCGA-FU-A3HZ-01A-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5566764
TCGA-HM-A4S6,TCGA-HM-A4S6-01A-11R-A26T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.7421943
TCGA-IR-A3L7,TCGA-IR-A3L7-01A-21R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.7151685
TCGA-IR-A3LC,TCGA-IR-A3LC-01A-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.6607641
TCGA-IR-A3LH,TCGA-IR-A3LH-01A-21R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.8198684
TCGA-IR-A3LL,TCGA-IR-A3LL-01A-11R-A213-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.7186519
TCGA-MA-AA3W,TCGA-MA-AA3W-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.7592133
TCGA-MA-AA3X,TCGA-MA-AA3X-01A-22R-A42S-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.4689622
TCGA-MY-A5BD,TCGA-MY-A5BD-01A-11R-A26T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.3956227
TCGA-MY-A5BF,TCGA-MY-A5BF-11A-11R-A26T-07,Solid Tissue Normal,Cisplatin,5702198,Complete Response,CESC,3.8128777
TCGA-MY-A5BF,TCGA-MY-A5BF-01A-11R-A26T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.7629883
TCGA-MY-A913,TCGA-MY-A913-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9816557
TCGA-Q1-A5R2,TCGA-Q1-A5R2-01A-11R-A28H-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,2.0881066
TCGA-Q1-A5R3,TCGA-Q1-A5R3-01A-11R-A28H-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,2.788181
TCGA-Q1-A73O,TCGA-Q1-A73O-01A-11R-A32P-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.7443959
TCGA-UC-A7PG,TCGA-UC-A7PG-01A-11R-A42S-07,Primary Tumor,cisplatin,5702198,Clinical Progressive Disease,CESC,2.7102582
TCGA-UC-A7PG,TCGA-UC-A7PG-06A-11R-A42S-07,Metastatic,cisplatin,5702198,Clinical Progressive Disease,CESC,2.0864794
TCGA-VS-A8EH,TCGA-VS-A8EH-01A-11R-A36F-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.9861188
TCGA-VS-A8EI,TCGA-VS-A8EI-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.889924
TCGA-VS-A8EK,TCGA-VS-A8EK-01A-12R-A37O-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,3.1365175
TCGA-VS-A8EL,TCGA-VS-A8EL-01A-11R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.6405797
TCGA-VS-A8QC,TCGA-VS-A8QC-01A-11R-A37O-07,Primary Tumor,Paclitaxel,36314,Clinical Progressive Disease,CESC,-4.484217
TCGA-VS-A8QF,TCGA-VS-A8QF-01A-21R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.3614337
TCGA-VS-A94W,TCGA-VS-A94W-01A-12R-A37O-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.8402426
TCGA-VS-A94X,TCGA-VS-A94X-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Partial Response,CESC,1.9232905
TCGA-VS-A94Y,TCGA-VS-A94Y-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,3.1342907
TCGA-VS-A94Z,TCGA-VS-A94Z-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.9393965
TCGA-VS-A954,TCGA-VS-A954-01A-11R-A38B-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.1099484
TCGA-VS-A957,TCGA-VS-A957-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.3212848
TCGA-VS-A958,TCGA-VS-A958-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.4928205
TCGA-VS-A9U5,TCGA-VS-A9U5-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.2082238
TCGA-VS-A9U6,TCGA-VS-A9U6-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Stable Disease,CESC,2.3195837
TCGA-VS-A9U7,TCGA-VS-A9U7-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.3304348
TCGA-VS-A9UB,TCGA-VS-A9UB-01A-22R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.1481441
TCGA-VS-A9UC,TCGA-VS-A9UC-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Stable Disease,CESC,3.204905
TCGA-VS-A9UD,TCGA-VS-A9UD-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.5740445
TCGA-VS-A9UH,TCGA-VS-A9UH-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,1.7449287
TCGA-VS-A9UO,TCGA-VS-A9UO-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.8770802
TCGA-VS-A9UP,TCGA-VS-A9UP-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5672956
TCGA-VS-A9UR,TCGA-VS-A9UR-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.5132985
TCGA-VS-A9UU,TCGA-VS-A9UU-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.9336839
TCGA-VS-A9UY,TCGA-VS-A9UY-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,1.8004789
TCGA-VS-A9V0,TCGA-VS-A9V0-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.505486
TCGA-VS-A9V1,TCGA-VS-A9V1-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,3.2589624
TCGA-VS-A9V3,TCGA-VS-A9V3-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Complete Response,CESC,2.1493957
TCGA-VS-A9V5,TCGA-VS-A9V5-01A-11R-A42T-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,CESC,3.0366993
TCGA-VS-AA62,TCGA-VS-AA62-01A-11R-A42T-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,CESC,1.6066129
TCGA-CF-A47S,TCGA-CF-A47S-01A-11R-A23W-07,Primary Tumor,Doxobubicin,31703,Complete Response,BLCA,-2.0264606
TCGA-DK-A6B2,TCGA-DK-A6B2-01A-11R-A30C-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,BLCA,-0.623683
TCGA-DK-AA6W,TCGA-DK-AA6W-01A-12R-A39I-07,Primary Tumor,Gemcitabine,60750,Stable Disease,BLCA,-3.4466252
TCGA-GV-A3QI,TCGA-GV-A3QI-01A-11R-A220-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,BLCA,-2.7372231
TCGA-4G-AAZO,TCGA-4G-AAZO-01A-12R-A41I-07,Primary Tumor,GEMCITABINE,60750,Stable Disease,CHOL,-0.7534833
TCGA-W5-AA2H,TCGA-W5-AA2H-01A-31R-A41I-07,Primary Tumor,gemcitabine,60750,Complete Response,CHOL,-4.048406
TCGA-W5-AA2T,TCGA-W5-AA2T-01A-12R-A41I-07,Primary Tumor,Gemcitabine,60750,Complete Response,CHOL,-1.0582595
TCGA-ZH-A8Y4,TCGA-ZH-A8Y4-01A-11R-A41I-07,Primary Tumor,Gemzar,60750,Partial Response,CHOL,-1.0858474
TCGA-JY-A93D,TCGA-JY-A93D-01A-11R-A38D-31,Primary Tumor,Fluorouracil,3385,Complete Response,ESCA,4.9138303
TCGA-LN-A49M,TCGA-LN-A49M-01A-21R-A260-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,1.0823534
TCGA-LN-A49O,TCGA-LN-A49O-01A-11R-A24K-31,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,ESCA,0.7850713
TCGA-LN-A49Y,TCGA-LN-A49Y-01A-11R-A260-31,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,ESCA,0.6670488
TCGA-LN-A4A6,TCGA-LN-A4A6-01A-11R-A260-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,0.38102913
TCGA-LN-A5U6,TCGA-LN-A5U6-01A-11R-A28J-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,0.9985759
TCGA-LN-A7HV,TCGA-LN-A7HV-01A-21R-A354-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,0.64003336
TCGA-LN-A7HX,TCGA-LN-A7HX-01A-11R-A336-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,0.25293708
TCGA-LN-A9FP,TCGA-LN-A9FP-01A-31R-A38D-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,2.2692344
TCGA-LN-A9FR,TCGA-LN-A9FR-01A-11R-A38D-31,Primary Tumor,Capecitabine,60953,Complete Response,ESCA,0.67796993
TCGA-VR-A8EQ,TCGA-VR-A8EQ-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,ESCA,4.6399393
TCGA-PK-A5HB,TCGA-PK-A5HB-01A-11R-A29S-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,ACC,2.6536517
TCGA-KN-8428,TCGA-KN-8428-11A-01R-2315-07,Solid Tissue Normal,sorafenib,216239,Clinical Progressive Disease,KICH,3.185547
TCGA-KN-8428,TCGA-KN-8428-01A-11R-2315-07,Primary Tumor,sorafenib,216239,Clinical Progressive Disease,KICH,2.6714036
TCGA-BA-A4IF,TCGA-BA-A4IF-01A-11R-A266-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.7301426
TCGA-BA-A4IH,TCGA-BA-A4IH-01A-11R-A266-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,1.532542
TCGA-BA-A6D8,TCGA-BA-A6D8-01A-31R-A31N-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.0435386
TCGA-BA-A6DA,TCGA-BA-A6DA-01A-31R-A31N-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.4169884
TCGA-BA-A6DD,TCGA-BA-A6DD-01A-12R-A31N-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,HNSC,2.348051
TCGA-BA-A6DI,TCGA-BA-A6DI-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.7918057
TCGA-BA-A6DJ,TCGA-BA-A6DJ-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.4261236
TCGA-BB-7864,TCGA-BB-7864-01A-11R-2232-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.0636945
TCGA-BB-7866,TCGA-BB-7866-01A-11R-2232-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,1.5405164
TCGA-BB-7872,TCGA-BB-7872-01A-11R-2232-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.3993602
TCGA-BB-A5HU,TCGA-BB-A5HU-01A-11R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.431133
TCGA-BB-A5HY,TCGA-BB-A5HY-01A-11R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.6330445
TCGA-CN-6998,TCGA-CN-6998-01A-23R-2016-07,Primary Tumor,cisplatin,5702198,Clinical Progressive Disease,HNSC,2.4918454
TCGA-CN-A49A,TCGA-CN-A49A-01A-11R-A24H-07,Primary Tumor,carboplatin,426756,Complete Response,HNSC,3.29915
TCGA-CN-A63T,TCGA-CN-A63T-01A-11R-A28V-07,Primary Tumor,CISPLATIN,5702198,Complete Response,HNSC,2.9816594
TCGA-CN-A641,TCGA-CN-A641-01A-11R-A30B-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.8638062
TCGA-CN-A6UY,TCGA-CN-A6UY-01A-12R-A34R-07,Primary Tumor,carboplatin,426756,Complete Response,HNSC,2.169835
TCGA-CN-A6V3,TCGA-CN-A6V3-01A-12R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.1875591
TCGA-CN-A6V6,TCGA-CN-A6V6-01A-12R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,1.6925162
TCGA-CN-A6V7,TCGA-CN-A6V7-01A-12R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.1837356
TCGA-CQ-A4CH,TCGA-CQ-A4CH-01A-11R-A266-07,Primary Tumor,cisplatin,5702198,Partial Response,HNSC,2.8109612
TCGA-D6-A6EK,TCGA-D6-A6EK-01A-11R-A31N-07,Primary Tumor,cisplatin,5702198,Partial Response,HNSC,3.314551
TCGA-DQ-7595,TCGA-DQ-7595-01A-11R-2232-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.4192681
TCGA-F7-A50J,TCGA-F7-A50J-01A-21R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.4830825
TCGA-HD-8314,TCGA-HD-8314-01A-11R-2403-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.3542137
TCGA-IQ-A61E,TCGA-IQ-A61E-01A-22R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.4866967
TCGA-IQ-A61G,TCGA-IQ-A61G-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,HNSC,2.5665622
TCGA-IQ-A61J,TCGA-IQ-A61J-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.1704586
TCGA-IQ-A61O,TCGA-IQ-A61O-01A-11R-A30B-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.9705033
TCGA-KU-A6H7,TCGA-KU-A6H7-01A-11R-A31N-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,1.993366
TCGA-KU-A6H7,TCGA-KU-A6H7-06A-21R-A31N-07,Metastatic,Cisplatin,5702198,Complete Response,HNSC,2.4582603
TCGA-MZ-A5BI,TCGA-MZ-A5BI-01A-31R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.0374207
TCGA-P3-A5Q6,TCGA-P3-A5Q6-01A-11R-A28V-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.7275293
TCGA-P3-A6SW,TCGA-P3-A6SW-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.1992846
TCGA-P3-A6T2,TCGA-P3-A6T2-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.3358128
TCGA-P3-A6T3,TCGA-P3-A6T3-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.2110798
TCGA-P3-A6T6,TCGA-P3-A6T6-01A-11R-A34R-07,Primary Tumor,Taxol,36314,Clinical Progressive Disease,HNSC,-3.7999673
TCGA-P3-A6T7,TCGA-P3-A6T7-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.5085163
TCGA-P3-A6T8,TCGA-P3-A6T8-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,3.4054008
TCGA-T2-A6X0,TCGA-T2-A6X0-01A-11R-A34R-07,Primary Tumor,cisplatin,5702198,Complete Response,HNSC,2.4333112
TCGA-TN-A7HJ,TCGA-TN-A7HJ-01A-12R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.9093628
TCGA-TN-A7HL,TCGA-TN-A7HL-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.073617
TCGA-UF-A7JC,TCGA-UF-A7JC-01A-21R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.8176808
TCGA-UF-A7JF,TCGA-UF-A7JF-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.6306918
TCGA-UF-A7JJ,TCGA-UF-A7JJ-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.7497983
TCGA-UF-A7JK,TCGA-UF-A7JK-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.5258276
TCGA-UF-A7JT,TCGA-UF-A7JT-01A-11R-A34R-07,Primary Tumor,Cisplatin,5702198,Complete Response,HNSC,2.0189142
TCGA-2Y-A9GV,TCGA-2Y-A9GV-01A-11R-A38B-07,Primary Tumor,Naxavar,216239,Clinical Progressive Disease,LIHC,2.4246485
TCGA-BC-A8YO,TCGA-BC-A8YO-01A-11R-A37K-07,Primary Tumor,Nexavar,216239,Partial Response,LIHC,2.0975242
TCGA-BW-A5NP,TCGA-BW-A5NP-01A-11R-A27V-07,Primary Tumor,Nexavar,216239,Clinical Progressive Disease,LIHC,2.6358395
TCGA-CC-A8HV,TCGA-CC-A8HV-01A-11R-A36F-07,Primary Tumor,Nexavar,216239,Clinical Progressive Disease,LIHC,2.7397554
TCGA-DD-A1EJ,TCGA-DD-A1EJ-01A-11R-A155-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.4998662
TCGA-DD-A1EJ,TCGA-DD-A1EJ-11A-11R-A155-07,Solid Tissue Normal,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.7112737
TCGA-DD-A1EK,TCGA-DD-A1EK-01A-11R-A213-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.940186
TCGA-DD-A3A4,TCGA-DD-A3A4-11A-11R-A22L-07,Solid Tissue Normal,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-1.5263565
TCGA-DD-A3A4,TCGA-DD-A3A4-01A-11R-A22L-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-0.9596281
TCGA-DD-A4NH,TCGA-DD-A4NH-01A-11R-A27V-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.7522748
TCGA-FV-A3I0,TCGA-FV-A3I0-11A-11R-A22L-07,Solid Tissue Normal,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-0.9923029
TCGA-FV-A3I0,TCGA-FV-A3I0-01A-11R-A22L-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,LIHC,-0.75735235
TCGA-G3-A3CG,TCGA-G3-A3CG-01A-11R-A213-07,Primary Tumor,Sorafenib,216239,Stable Disease,LIHC,2.5311148
TCGA-G3-A3CJ,TCGA-G3-A3CJ-01A-11R-A213-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.6737971
TCGA-G3-A5SI,TCGA-G3-A5SI-01A-31R-A27V-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,2.7651014
TCGA-WX-AA44,TCGA-WX-AA44-01A-11R-A39D-07,Primary Tumor,SORAFENIB,216239,Partial Response,LIHC,2.6763463
TCGA-WX-AA47,TCGA-WX-AA47-01A-11R-A39D-07,Primary Tumor,Sorafenib,216239,Clinical Progressive Disease,LIHC,3.075459
TCGA-LK-A4NZ,TCGA-LK-A4NZ-01A-12R-A34F-07,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,MESO,2.422884
TCGA-LK-A4O0,TCGA-LK-A4O0-01A-11R-A34F-07,Primary Tumor,Cisplatinum,5702198,Complete Response,MESO,2.2859385
TCGA-19-5960,TCGA-19-5960-01A-11R-1850-01,Primary Tumor,Temodar,5394,Stable Disease,GBM,6.3292
TCGA-DB-A4XB,TCGA-DB-A4XB-01A-11R-A26U-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3533864
TCGA-DB-A4XD,TCGA-DB-A4XD-01A-11R-A27Q-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.4768877
TCGA-DB-A4XF,TCGA-DB-A4XF-01A-11R-A27Q-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.4729147
TCGA-DB-A4XG,TCGA-DB-A4XG-01A-11R-A27Q-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.4387302
TCGA-DB-A64O,TCGA-DB-A64O-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3761435
TCGA-DB-A64P,TCGA-DB-A64P-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.541016
TCGA-DB-A64V,TCGA-DB-A64V-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.2356133
TCGA-DB-A64W,TCGA-DB-A64W-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.2802305
TCGA-DB-A64X,TCGA-DB-A64X-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.484552
TCGA-DB-A75K,TCGA-DB-A75K-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,6.1952667
TCGA-DH-A66B,TCGA-DH-A66B-01A-11R-A29R-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.33026
TCGA-DH-A66D,TCGA-DH-A66D-01A-11R-A31N-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.530118
TCGA-DH-A66G,TCGA-DH-A66G-01A-21R-A31N-07,Primary Tumor,Temodar,5394,Partial Response,LGG,6.3378277
TCGA-DH-A7UR,TCGA-DH-A7UR-01A-11R-A33Z-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.2530766
TCGA-DH-A7UT,TCGA-DH-A7UT-01A-12R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.419766
TCGA-DH-A7UU,TCGA-DH-A7UU-01A-12R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.2374644
TCGA-DH-A7UV,TCGA-DH-A7UV-01A-12R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.51833
TCGA-DU-8162,TCGA-DU-8162-01A-21R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.426146
TCGA-DU-8163,TCGA-DU-8163-01A-11R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.2828217
TCGA-DU-8165,TCGA-DU-8165-01A-11R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.1041374
TCGA-DU-8168,TCGA-DU-8168-01A-11R-2256-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.4081845
TCGA-DU-A5TP,TCGA-DU-A5TP-01A-11R-A28M-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.029253
TCGA-DU-A5TS,TCGA-DU-A5TS-01A-11R-A28M-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.5200386
TCGA-DU-A5TU,TCGA-DU-A5TU-01A-11R-A28M-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.1417065
TCGA-DU-A6S6,TCGA-DU-A6S6-01A-21R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.2437506
TCGA-DU-A6S7,TCGA-DU-A6S7-01A-21R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.5277805
TCGA-DU-A76K,TCGA-DU-A76K-01A-11R-A33Z-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.4265947
TCGA-DU-A76O,TCGA-DU-A76O-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.2492013
TCGA-DU-A76R,TCGA-DU-A76R-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.66562
TCGA-DU-A7TA,TCGA-DU-A7TA-01A-11R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3213205
TCGA-E1-A7YK,TCGA-E1-A7YK-01A-11R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3606853
TCGA-E1-A7YS,TCGA-E1-A7YS-01A-11R-A34F-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3833055
TCGA-FG-6689,TCGA-FG-6689-01A-11R-1896-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.318311
TCGA-FG-7638,TCGA-FG-7638-01B-12R-2090-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.4555416
TCGA-FG-8181,TCGA-FG-8181-01A-11R-2256-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.657954
TCGA-FG-8189,TCGA-FG-8189-01B-11R-A28M-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.381577
TCGA-FG-8191,TCGA-FG-8191-01A-11R-2256-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.6045113
TCGA-FG-A4MW,TCGA-FG-A4MW-01A-11R-A26U-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.4791136
TCGA-FG-A6J3,TCGA-FG-A6J3-01A-11R-A31N-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3038416
TCGA-FG-A70Y,TCGA-FG-A70Y-01A-12R-A34R-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.457627
TCGA-FG-A710,TCGA-FG-A710-01A-12R-A33Z-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3412924
TCGA-FN-7833,TCGA-FN-7833-01A-11R-2090-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,6.0651445
TCGA-HT-7477,TCGA-HT-7477-01B-11R-A28M-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.0343423
TCGA-HT-7483,TCGA-HT-7483-01A-11R-2027-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.2305846
TCGA-HT-7604,TCGA-HT-7604-01A-11R-2090-07,Primary Tumor,Temodar,5394,Partial Response,LGG,6.2102656
TCGA-HT-7884,TCGA-HT-7884-01B-11R-2403-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.374205
TCGA-HT-8013,TCGA-HT-8013-01A-11R-2403-07,Primary Tumor,Temodar,5394,Clinical Progressive Disease,LGG,6.2502007
TCGA-HT-8114,TCGA-HT-8114-01A-11R-2404-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.32932
TCGA-HT-A5RA,TCGA-HT-A5RA-01A-11R-A28M-07,Primary Tumor,Temodar,5394,Partial Response,LGG,6.1579647
TCGA-HT-A5RC,TCGA-HT-A5RC-01A-11R-A28M-07,Primary Tumor,Temodar,5394,Clinical Progressive Disease,LGG,6.024493
TCGA-HT-A619,TCGA-HT-A619-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.2946787
TCGA-HT-A61C,TCGA-HT-A61C-01A-11R-A29R-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.2572427
TCGA-HT-A74K,TCGA-HT-A74K-01A-11R-A32Q-07,Primary Tumor,temodar,5394,Complete Response,LGG,6.3507733
TCGA-HW-8320,TCGA-HW-8320-01A-11R-2404-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3313417
TCGA-HW-8321,TCGA-HW-8321-01A-11R-2404-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.520826
TCGA-HW-A5KK,TCGA-HW-A5KK-01A-11R-A27Q-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.4849124
TCGA-HW-A5KL,TCGA-HW-A5KL-01A-11R-A27Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3050957
TCGA-IK-8125,TCGA-IK-8125-01A-11R-2256-07,Primary Tumor,Temodar,5394,Complete Response,LGG,6.300085
TCGA-KT-A74X,TCGA-KT-A74X-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.5338626
TCGA-KT-A7W1,TCGA-KT-A7W1-01A-11R-A34F-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,5.9446855
TCGA-P5-A5EX,TCGA-P5-A5EX-01A-12R-A28M-07,Primary Tumor,Temozolomide,5394,Partial Response,LGG,6.197756
TCGA-QH-A65R,TCGA-QH-A65R-01A-21R-A31N-07,Primary Tumor,TEMOZOLOMIDE,5394,Stable Disease,LGG,6.586395
TCGA-QH-A6CY,TCGA-QH-A6CY-01A-11R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.662613
TCGA-QH-A6X4,TCGA-QH-A6X4-01A-51R-A32Q-07,Primary Tumor,temozolomide,5394,Clinical Progressive Disease,LGG,6.4377117
TCGA-QH-A6X8,TCGA-QH-A6X8-01A-12R-A32Q-07,Primary Tumor,temozolomide,5394,Stable Disease,LGG,6.5632153
TCGA-S9-A6TV,TCGA-S9-A6TV-01A-12R-A34R-07,Primary Tumor,Temozolamide,5394,Stable Disease,LGG,6.410433
TCGA-S9-A6TW,TCGA-S9-A6TW-01A-12R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.817442
TCGA-S9-A6TX,TCGA-S9-A6TX-01A-21R-A32Q-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,6.6571136
TCGA-S9-A6TY,TCGA-S9-A6TY-01A-12R-A32Q-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.339956
TCGA-S9-A6U1,TCGA-S9-A6U1-01A-21R-A33Z-07,Primary Tumor,Temozolomide,5394,Complete Response,LGG,6.169936
TCGA-S9-A6WD,TCGA-S9-A6WD-01A-12R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.4328766
TCGA-S9-A6WG,TCGA-S9-A6WG-01A-11R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.5670853
TCGA-S9-A6WM,TCGA-S9-A6WM-01A-12R-A33Z-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.109556
TCGA-S9-A7QW,TCGA-S9-A7QW-01A-11R-A34F-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.4082327
TCGA-S9-A7QY,TCGA-S9-A7QY-01A-11R-A34F-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.3584146
TCGA-S9-A7R1,TCGA-S9-A7R1-01A-12R-A34R-07,Primary Tumor,Temozolamide,5394,Stable Disease,LGG,6.5914044
TCGA-S9-A7R4,TCGA-S9-A7R4-01A-12R-A34R-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.7708144
TCGA-S9-A89V,TCGA-S9-A89V-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.4556503
TCGA-S9-A89Z,TCGA-S9-A89Z-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.2246733
TCGA-TM-A84B,TCGA-TM-A84B-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,5.9270544
TCGA-TM-A84C,TCGA-TM-A84C-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.3199167
TCGA-TM-A84L,TCGA-TM-A84L-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Clinical Progressive Disease,LGG,6.289863
TCGA-VM-A8C8,TCGA-VM-A8C8-01A-11R-A36H-07,Primary Tumor,Temozolomide,5394,Stable Disease,LGG,6.4657845
TCGA-VM-A8CF,TCGA-VM-A8CF-01A-11R-A36H-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.3195143
TCGA-VV-A829,TCGA-VV-A829-01A-21R-A36H-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.689903
TCGA-VW-A7QS,TCGA-VW-A7QS-01A-12R-A33Z-07,Primary Tumor,Temodar,5394,Partial Response,LGG,6.487373
TCGA-WH-A86K,TCGA-WH-A86K-01A-11R-A36H-07,Primary Tumor,Temodar,5394,Stable Disease,LGG,6.5042887
TCGA-3B-A9HT,TCGA-3B-A9HT-01A-11R-A39D-07,Primary Tumor,CISPLATINUM,5702198,Complete Response,SARC,1.8829892
TCGA-DX-A6B8,TCGA-DX-A6B8-01A-11R-A30C-07,Primary Tumor,Adriamycin,31703,Clinical Progressive Disease,SARC,-0.7102504
TCGA-FX-A3RE,TCGA-FX-A3RE-01A-11R-A22K-07,Primary Tumor,Adriamycin,31703,Complete Response,SARC,-1.9462948
TCGA-IF-A3RQ,TCGA-IF-A3RQ-01A-11R-A22K-07,Primary Tumor,Adriamycin,31703,Partial Response,SARC,-0.9824045
TCGA-IF-A4AJ,TCGA-IF-A4AJ-01A-11R-A24X-07,Primary Tumor,Adriamycin,31703,Clinical Progressive Disease,SARC,-2.3232522
TCGA-IS-A3K7,TCGA-IS-A3K7-01A-11R-A21T-07,Primary Tumor,Doxorubicin,31703,Partial Response,SARC,-1.1618624
TCGA-K1-A6RU,TCGA-K1-A6RU-01A-11R-A32Q-07,Primary Tumor,Adriamycin,31703,Clinical Progressive Disease,SARC,-0.90099645
TCGA-LI-A67I,TCGA-LI-A67I-01A-31R-A30C-07,Primary Tumor,Doxil,31703,Clinical Progressive Disease,SARC,-1.7648594
TCGA-MO-A47P,TCGA-MO-A47P-01A-11R-A24X-07,Primary Tumor,Doxorubicin,31703,Complete Response,SARC,-1.1859808
TCGA-X6-A7WC,TCGA-X6-A7WC-01A-12R-A355-07,Primary Tumor,Gemcitabine,60750,Stable Disease,SARC,-3.5180492
TCGA-AF-A56N,TCGA-AF-A56N-01A-12R-A39D-07,Primary Tumor,xeloda,60953,Complete Response,READ,-0.2523563
TCGA-AG-3593,TCGA-AG-3593-01A-01R-0821-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.2896488
TCGA-AG-3600,TCGA-AG-3600-01A-01R-0826-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.1984503
TCGA-AG-3894,TCGA-AG-3894-01A-01R-1119-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,2.915559
TCGA-AG-4022,TCGA-AG-4022-01A-01R-1736-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,2.987485
TCGA-AG-A00H,TCGA-AG-A00H-01A-01R-A00A-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,4.3219423
TCGA-AG-A01L,TCGA-AG-A01L-01A-01R-A002-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,2.7714348
TCGA-AG-A01W,TCGA-AG-A01W-01A-21R-A083-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,2.9434202
TCGA-AG-A01Y,TCGA-AG-A01Y-01A-41R-A083-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,3.2635155
TCGA-AG-A036,TCGA-AG-A036-01A-12R-A083-07,Primary Tumor,5-Fluorouracil,3385,Complete Response,READ,2.685132
TCGA-DY-A1DC,TCGA-DY-A1DC-01A-31R-A155-07,Primary Tumor,Capecitabine -xeloda,60953,Partial Response,READ,0.5401255
TCGA-2L-AAQA,TCGA-2L-AAQA-01A-21R-A38C-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.8395329
TCGA-2L-AAQE,TCGA-2L-AAQE-01A-11R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.067257
TCGA-2L-AAQI,TCGA-2L-AAQI-01A-12R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-0.55176663
TCGA-2L-AAQJ,TCGA-2L-AAQJ-01A-12R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.658982
TCGA-3A-A9IZ,TCGA-3A-A9IZ-01A-12R-A41B-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.9428043
TCGA-F2-6879,TCGA-F2-6879-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Partial Response,PAAD,-1.0805521
TCGA-F2-6880,TCGA-F2-6880-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-1.3596754
TCGA-F2-7276,TCGA-F2-7276-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.781057
TCGA-F2-A8YN,TCGA-F2-A8YN-01A-11R-A37L-07,Primary Tumor,Gemzar,60750,Clinical Progressive Disease,PAAD,-0.5713532
TCGA-FB-A78T,TCGA-FB-A78T-01A-12R-A32O-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-1.7268906
TCGA-FB-AAPY,TCGA-FB-AAPY-01A-11R-A41B-07,Primary Tumor,Gemzar,60750,Complete Response,PAAD,-2.4088702
TCGA-FB-AAQ6,TCGA-FB-AAQ6-01A-11R-A41B-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-0.74428725
TCGA-HV-AA8X,TCGA-HV-AA8X-01A-11R-A39D-07,Primary Tumor,Gemcitabine Injection,60750,Clinical Progressive Disease,PAAD,0.5051894
TCGA-HZ-7920,TCGA-HZ-7920-01A-11R-2204-07,Primary Tumor,5-FU,3385,Complete Response,PAAD,4.4085693
TCGA-HZ-7923,TCGA-HZ-7923-01A-12R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-3.6275325
TCGA-HZ-7924,TCGA-HZ-7924-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-1.5222607
TCGA-HZ-8317,TCGA-HZ-8317-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-0.70193696
TCGA-HZ-8637,TCGA-HZ-8637-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-3.5280952
TCGA-HZ-A49G,TCGA-HZ-A49G-01A-11R-A26U-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.4125009
TCGA-HZ-A49H,TCGA-HZ-A49H-01A-11R-A26U-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-2.7305183
TCGA-HZ-A49I,TCGA-HZ-A49I-01A-12R-A26U-07,Primary Tumor,5-FU,3385,Clinical Progressive Disease,PAAD,5.4148355
TCGA-HZ-A77O,TCGA-HZ-A77O-01A-11R-A33R-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-0.9413667
TCGA-HZ-A77P,TCGA-HZ-A77P-01A-11R-A33R-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-0.8545859
TCGA-IB-7644,TCGA-IB-7644-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.9434586
TCGA-IB-7647,TCGA-IB-7647-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.4609232
TCGA-IB-7652,TCGA-IB-7652-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-1.9292042
TCGA-IB-7885,TCGA-IB-7885-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-2.3292627
TCGA-IB-7889,TCGA-IB-7889-01A-11R-2156-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.2534397
TCGA-IB-8126,TCGA-IB-8126-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.6370258
TCGA-IB-8127,TCGA-IB-8127-01A-11R-2404-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-1.3150513
TCGA-IB-A5SO,TCGA-IB-A5SO-01A-11R-A32O-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.2713363
TCGA-IB-A5SP,TCGA-IB-A5SP-01A-11R-A32O-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,0.060515165
TCGA-IB-A5SS,TCGA-IB-A5SS-01A-11R-A32O-07,Primary Tumor,Gemcitabine,60750,Partial Response,PAAD,-1.7039802
TCGA-IB-AAUO,TCGA-IB-AAUO-01A-12R-A38C-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.3074927
TCGA-L1-A7W4,TCGA-L1-A7W4-01A-12R-A36G-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.8965821
TCGA-Q3-A5QY,TCGA-Q3-A5QY-01A-12R-A32O-07,Primary Tumor,Gemcitabine,60750,Partial Response,PAAD,-3.9921913
TCGA-RB-AA9M,TCGA-RB-AA9M-01A-11R-A39D-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-1.3882267
TCGA-S4-A8RM,TCGA-S4-A8RM-01A-11R-A37L-07,Primary Tumor,Gemzar,60750,Complete Response,PAAD,-1.4436872
TCGA-US-A774,TCGA-US-A774-01A-21R-A32O-07,Primary Tumor,Gemcitabine,60750,Clinical Progressive Disease,PAAD,-2.664332
TCGA-YB-A89D,TCGA-YB-A89D-11A-11R-A36G-07,Solid Tissue Normal,Gemcitabine,60750,Complete Response,PAAD,-2.7411294
TCGA-YB-A89D,TCGA-YB-A89D-01A-12R-A36G-07,Primary Tumor,Gemcitabine,60750,Complete Response,PAAD,-1.0953236
TCGA-49-AAR2,TCGA-49-AAR2-01A-11R-A39D-07,Primary Tumor,TAXOL,36314,Complete Response,LUAD,-3.5850801
TCGA-50-5068,TCGA-50-5068-01A-01R-1628-07,Primary Tumor,Taxol,36314,Clinical Progressive Disease,LUAD,-1.8881214
TCGA-50-5936,TCGA-50-5936-01A-11R-1628-07,Primary Tumor,TAXOL,36314,Clinical Progressive Disease,LUAD,-2.169076
TCGA-50-5936,TCGA-50-5936-11A-01R-1628-07,Solid Tissue Normal,TAXOL,36314,Clinical Progressive Disease,LUAD,-2.5013847
TCGA-50-6595,TCGA-50-6595-01A-12R-1858-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,LUAD,3.2774985
TCGA-50-6595,TCGA-50-6595-11A-01R-1858-07,Solid Tissue Normal,Carboplatin,426756,Clinical Progressive Disease,LUAD,3.7106462
TCGA-55-7910,TCGA-55-7910-01A-11R-2170-07,Primary Tumor,Cisplatin,5702198,Complete Response,LUAD,3.3037882
TCGA-93-A4JP,TCGA-93-A4JP-01A-11R-A24X-07,Primary Tumor,Carboplatin,426756,Partial Response,LUAD,2.9348328
TCGA-2A-A8VT,TCGA-2A-A8VT-01A-11R-A37L-07,Primary Tumor,Lupron,657181,Stable Disease,PRAD,1.2719367
TCGA-CH-5741,TCGA-CH-5741-01A-11R-1580-07,Primary Tumor,Leuprorelin,657181,Complete Response,PRAD,1.7091361
TCGA-HC-7742,TCGA-HC-7742-11A-01R-2118-07,Solid Tissue Normal,Eligard,657181,Partial Response,PRAD,1.7797033
TCGA-HC-7742,TCGA-HC-7742-01A-11R-2118-07,Primary Tumor,Eligard,657181,Partial Response,PRAD,1.0885754
TCGA-HC-A9TE,TCGA-HC-A9TE-01A-11R-A41O-07,Primary Tumor,Eligard,657181,Stable Disease,PRAD,1.6073872
TCGA-HI-7168,TCGA-HI-7168-01A-11R-2118-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.5803306
TCGA-KC-A4BR,TCGA-KC-A4BR-01A-32R-A32Y-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.5387814
TCGA-KK-A59Y,TCGA-KK-A59Y-01A-11R-A26U-07,Primary Tumor,Leuprolide Acetate,657181,Complete Response,PRAD,1.0747796
TCGA-KK-A6E1,TCGA-KK-A6E1-01A-11R-A311-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,0.70921767
TCGA-KK-A8I4,TCGA-KK-A8I4-01A-11R-A36G-07,Primary Tumor,Lupron,657181,Stable Disease,PRAD,1.3725003
TCGA-KK-A8I7,TCGA-KK-A8I7-01A-21R-A36G-07,Primary Tumor,Leuprolide Acetate,657181,Complete Response,PRAD,1.4547839
TCGA-KK-A8I9,TCGA-KK-A8I9-01A-11R-A36G-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.3741293
TCGA-KK-A8ID,TCGA-KK-A8ID-01A-11R-A36G-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.8643069
TCGA-YL-A9WL,TCGA-YL-A9WL-01A-11R-A41O-07,Primary Tumor,Lupron,657181,Complete Response,PRAD,1.1499871
TCGA-37-A5EL,TCGA-37-A5EL-01A-11R-A26W-07,Primary Tumor,Temodal,5394,Partial Response,LUSC,6.23646
TCGA-43-5668,TCGA-43-5668-01A-01R-1635-07,Primary Tumor,Gemzar,60750,Clinical Progressive Disease,LUSC,-3.2652402
TCGA-85-8664,TCGA-85-8664-01A-11R-2403-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,LUSC,2.756189
TCGA-90-A59Q,TCGA-90-A59Q-01A-11R-A26W-07,Primary Tumor,Cisplatin,5702198,Complete Response,LUSC,1.9935292
TCGA-2G-AAF1,TCGA-2G-AAF1-01A-11R-A430-07,Primary Tumor,Carboplatin,426756,Complete Response,TGCT,2.1213493
TCGA-WZ-A7V4,TCGA-WZ-A7V4-01A-11R-A431-07,Primary Tumor,Carboplatin,426756,Complete Response,TGCT,2.339691
TCGA-YU-A90Q,TCGA-YU-A90Q-01A-11R-A431-07,Primary Tumor,Carboplatin,426756,Complete Response,TGCT,2.521468
TCGA-XM-AAZ1,TCGA-XM-AAZ1-01A-11R-A42C-07,Primary Tumor,Cisplatin,5702198,Stable Disease,THYM,2.126907
TCGA-D3-A1Q3,TCGA-D3-A1Q3-06A-11R-A18T-07,Metastatic,Cisplatin,5702198,Complete Response,SKCM,2.4715693
TCGA-EB-A3XC,TCGA-EB-A3XC-01A-11R-A239-07,Primary Tumor,Dacarbazine,135398738,Complete Response,SKCM,5.3197303
TCGA-EB-A3Y6,TCGA-EB-A3Y6-01A-21R-A239-07,Primary Tumor,Dacarbazine,135398738,Complete Response,SKCM,5.421234
TCGA-EE-A185,TCGA-EE-A185-06A-11R-A18S-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.8598948
TCGA-EE-A29Q,TCGA-EE-A29Q-06A-11R-A18T-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.5325923
TCGA-EE-A29V,TCGA-EE-A29V-06A-12R-A18S-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.717428
TCGA-EE-A2MD,TCGA-EE-A2MD-06A-11R-A18T-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.4031506
TCGA-EE-A2MN,TCGA-EE-A2MN-06A-11R-A18S-07,Metastatic,Dacabarzine,135398738,Clinical Progressive Disease,SKCM,5.048023
TCGA-EE-A2MQ,TCGA-EE-A2MQ-06A-11R-A18S-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,4.8865232
TCGA-EE-A3JI,TCGA-EE-A3JI-06A-11R-A21D-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,5.4275293
TCGA-FR-A8YC,TCGA-FR-A8YC-06A-11R-A37K-07,Metastatic,2B3-101,31703,Clinical Progressive Disease,SKCM,-1.7279341
TCGA-HR-A2OH,TCGA-HR-A2OH-06A-11R-A18U-07,Metastatic,Dacarbazine,135398738,Clinical Progressive Disease,SKCM,4.9615784
TCGA-N6-A4VC,TCGA-N6-A4VC-01A-11R-A28V-07,Primary Tumor,Carboplatin,426756,Clinical Progressive Disease,UCS,2.6364646
TCGA-NA-A4QW,TCGA-NA-A4QW-01A-11R-A28V-07,Primary Tumor,Taxol,36314,Complete Response,UCS,-3.9032745
TCGA-ND-A4WC,TCGA-ND-A4WC-01A-21R-A28V-07,Primary Tumor,Carboplatin,426756,Complete Response,UCS,2.3986075
TCGA-B7-A5TK,TCGA-B7-A5TK-01A-12R-A36D-31,Primary Tumor,Xeloda,60953,Complete Response,STAD,1.4626881
TCGA-B7-A5TN,TCGA-B7-A5TN-01A-21R-A31P-31,Primary Tumor,Cisplatin,5702198,Complete Response,STAD,3.2197165
TCGA-BR-A4J8,TCGA-BR-A4J8-01A-11R-A251-31,Primary Tumor,Xeloda,60953,Complete Response,STAD,1.0366993
TCGA-CD-8533,TCGA-CD-8533-01A-11R-2343-13,Primary Tumor,Capecitabine,60953,Clinical Progressive Disease,STAD,0.911064
TCGA-CD-A48A,TCGA-CD-A48A-01A-12R-A36D-31,Primary Tumor,Capecitabine,60953,Complete Response,STAD,1.4887787
TCGA-CG-4444,TCGA-CG-4444-01A-01R-1157-13,Primary Tumor,5-Fluorouracil,3385,Complete Response,STAD,4.0131264
TCGA-CG-5724,TCGA-CG-5724-01A-11R-1602-13,Primary Tumor,Cisplatin,5702198,Clinical Progressive Disease,STAD,3.3398623
TCGA-D7-8579,TCGA-D7-8579-01A-11R-2343-13,Primary Tumor,5-fluorouracilum,3385,Complete Response,STAD,5.371968
TCGA-F1-A72C,TCGA-F1-A72C-01A-21R-A33Y-31,Primary Tumor,Capecitabine,60953,Complete Response,STAD,1.5994236
TCGA-FP-7829,TCGA-FP-7829-01A-11R-2055-13,Primary Tumor,5-FU,3385,Complete Response,STAD,3.989482
TCGA-FP-7829,TCGA-FP-7829-11A-01R-2055-13,Solid Tissue Normal,5-FU,3385,Complete Response,STAD,6.0069723
TCGA-FP-7916,TCGA-FP-7916-01A-11R-2203-13,Primary Tumor,Xeloda,60953,Clinical Progressive Disease,STAD,1.3056865
TCGA-FP-A4BE,TCGA-FP-A4BE-01A-12R-A24K-31,Primary Tumor,5-FU,3385,Complete Response,STAD,2.469976
TCGA-HU-8243,TCGA-HU-8243-01A-11R-2343-13,Primary Tumor,5-FU,3385,Complete Response,STAD,5.352433
TCGA-HU-8249,TCGA-HU-8249-01A-11R-A36D-31,Primary Tumor,Xeloda,60953,Complete Response,STAD,0.60490835
TCGA-HU-8602,TCGA-HU-8602-01A-11R-2402-13,Primary Tumor,Xeloda,60953,Complete Response,STAD,0.22118592
TCGA-KB-A6F7,TCGA-KB-A6F7-01A-12R-A32D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.9232552
TCGA-KB-A93J,TCGA-KB-A93J-01A-11R-A39E-31,Primary Tumor,5-fluorouracil,3385,Complete Response,STAD,3.624114
TCGA-VQ-A8DT,TCGA-VQ-A8DT-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.981628
TCGA-VQ-A8DU,TCGA-VQ-A8DU-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.3711286
TCGA-VQ-A8DZ,TCGA-VQ-A8DZ-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.8055205
TCGA-VQ-A8E0,TCGA-VQ-A8E0-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.6620274
TCGA-VQ-A8E2,TCGA-VQ-A8E2-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.8369339
TCGA-VQ-A8P3,TCGA-VQ-A8P3-01A-11R-A36D-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.570853
TCGA-VQ-A8PB,TCGA-VQ-A8PB-01A-11R-A39E-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.5841403
TCGA-VQ-A8PD,TCGA-VQ-A8PD-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.134673
TCGA-VQ-A8PP,TCGA-VQ-A8PP-01A-21R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.328433
TCGA-VQ-A8PU,TCGA-VQ-A8PU-01A-12R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,5.045015
TCGA-VQ-A91D,TCGA-VQ-A91D-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.745408
TCGA-VQ-A91E,TCGA-VQ-A91E-01A-31R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.5311317
TCGA-VQ-A91K,TCGA-VQ-A91K-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.7388146
TCGA-VQ-A91N,TCGA-VQ-A91N-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.7851076
TCGA-VQ-A91Q,TCGA-VQ-A91Q-01A-12R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,5.4194365
TCGA-VQ-A91S,TCGA-VQ-A91S-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.52677
TCGA-VQ-A91W,TCGA-VQ-A91W-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,2.556747
TCGA-VQ-A91Y,TCGA-VQ-A91Y-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.6003194
TCGA-VQ-A922,TCGA-VQ-A922-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.544099
TCGA-VQ-A928,TCGA-VQ-A928-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.8152742
TCGA-VQ-A94O,TCGA-VQ-A94O-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.1450377
TCGA-VQ-A94R,TCGA-VQ-A94R-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,3.7177262
TCGA-VQ-AA64,TCGA-VQ-AA64-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.8156967
TCGA-VQ-AA68,TCGA-VQ-AA68-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,4.4883246
TCGA-VQ-AA6B,TCGA-VQ-AA6B-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,3.665125
TCGA-VQ-AA6D,TCGA-VQ-AA6D-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Complete Response,STAD,5.3349247
TCGA-VQ-AA6F,TCGA-VQ-AA6F-01A-31R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,3.4947128
TCGA-VQ-AA6G,TCGA-VQ-AA6G-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,4.4488497
TCGA-VQ-AA6K,TCGA-VQ-AA6K-01A-11R-A414-31,Primary Tumor,Fluorouracil,3385,Clinical Progressive Disease,STAD,5.6711054
